Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
JAMA Network Open|December 26, 2024
Kidney Function Decline After COVID-19 InfectionViyaasan Mahalingasivam, Anne-Laure Faucon, Arvid Sjölander, et al.
Kidney International Reports|April 14, 2025
Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane DiseaseVanja Ivković, Ingeborg Bajema, Annette Bruchfeld, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 29, 2022
The role of dendrin in IgA nephropathyAnna Levin, Angelina Schwarz, Jenny Hulkko, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2020
Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitiumAnna Levin, Anna Reznichenko, Anna Witasp, et al.
The Journal of Rheumatology|July 17, 2019
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with PolyangiitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2025
Complement activation in secondary thrombotic microangiopathiesJohann Morelle, Fernando Caravaca-Fontan, Fadi Fakhouri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionEric Lawitz, Robert Flisiak, Manal Abunimeh, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2007
Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritisRichard S Goldstein, Annette Bruchfeld, Lihong Yang, et al.
Pageof 14